Home Tags Insulin
In Europe, Biocon Biologics portfolio includes 7 biosimilars: Insulin Aspart and Insulin Glargine, Bevacizumab, Pegfilgrastim, Trastuzumab, Adalimumab, and Etanercept
INSUQUICK is 100% Made in India with the potential to improve treatment access for people with diabetes
The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities and rising production of advanced insulin pumps
The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities
Demand for patch insulin pumps is predicted to rise at a CAGR of 10% from 2022 to 2032
Research indicates that continuous glucose monitoring has helped people with Type 2 diabetes either on long-acting insulin therapy or non-insulin OAD therapy, significantly reducing their HbA1c levels
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
Becomes the first biosimilar insulin company to partner with International Diabetes Federation for enabling affordable access to insulins to people with diabetes worldwide.................
Based on this year’s theme, ‘The Nurse and Diabetes’, it becomes even more important to raise awareness around the crucial role that nurses play in treating people living with diabetes.......................
Researchers from the Indian Institute of Technology, Mandi (IIT Mandi) have unraveled the mechanism by which insulin overload in the body causes insulin resistance that is associated with diabetes......................